Lima, Peru – Peru’s health ministry said on Saturday it had stopped testing for the Chinese Govt-19 vaccine after a participant raised health issues. The Ministry of Health says a test with 12,000 volunteers for China’s synopharmaceutical vaccine has been suspended because one of the participants examined what the vaccine described as a “severe adverse event”. The trial was expected to end in the coming days. German Mாlaga, a health researcher at the University of Caetano Heredia in Lima, where the experiment is taking place, presented with a volunteer neurological problem that caused him to have difficulty moving his legs. Dr Malaga told radio station RPP Notice that he did not believe there was a health problem due to the vaccine, but needed more information. “We are concerned about the situation and we offer all our help and support to ensure that it is eradicated,” he said. The United Arab Emirates said this week that its own test for the synoform vaccine shows that it is 86% effective in protecting people from Covit-19. The UAE investigation involves 31,000 people, although authorities have not released how many cases of infection are based on performance assessment. In most cases, the most reliable results are considered. Analyzing its efficacy against Govt-19 is limited to the vaccine developed in Beijing. Another strain has been created in Wuhan. In Peru, it is unclear which synoform strain was used in the country’s investigation. A spokesman for the Ministry of Health did not respond to requests for comment. Sinoform did not respond to a request for comment. Chinese vaccine manufacturers are under pressure to provide medical evidence that their test candidates are working, with leading Western vaccines developed by Pfizer Inc. and German partner Bioentech SE being shown to be highly effective. Public health experts have criticized China for approving its vaccines for emergency use before solid medical evidence can be provided. Synoform is testing its vaccines in Argentina, Bahrain, Egypt, Indonesia, Jordan, Morocco and Russia. Egypt and Indonesia have already received initial packages of vaccines. In China, nearly one million people have been vaccinated against sinoform, including Chinese workers, government officials and students. Peru has confirmed more than 36,500 deaths from Govt-19, one of the highest individual mortality rates in the world. The country of 32 million people has signed an agreement with Pfizer to receive about 9.9 million doses of its Covit-19 vaccine. Government officials believe the first batch of the vaccine will be available in March or April. Peru has also signed an agreement to obtain vaccines from a support initiative of the World Health Organization, known as Kovacs. The plan aims to distribute about 2 billion vaccines to poor countries by the end of 2021. Ha Kao Deng contributed to this article. Write to Ryan Tube at [email protected] Copyright © 2020 Dow Jones & Company, Inc. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8.
Source